$4.16
1.1638.67%
At close: -
$4.35
0.194.57%
After Hours: 7:59 PM EDT
Comments
Loading...
Dogwood Therapeutics Analyst Ratings and Price Targets | NASDAQ:DWTX | Benzinga
Dogwood Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Dogwood Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Dogwood Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Dogwood Therapeutics (DWTX) stock?
There is no price target for Dogwood Therapeutics
What is the most recent analyst rating for Dogwood Therapeutics (DWTX)?
There is no analyst for Dogwood Therapeutics
When was the last upgrade for Dogwood Therapeutics (DWTX)?
There is no last upgrade for Dogwood Therapeutics
When was the last downgrade for Dogwood Therapeutics (DWTX)?
There is no last downgrade for Dogwood Therapeutics.
When is the next analyst rating going to be posted or updated for Dogwood Therapeutics (DWTX)?
There is no next analyst rating for Dogwood Therapeutics.
Is the Analyst Rating Dogwood Therapeutics (DWTX) correct?
There is no next analyst rating for Dogwood Therapeutics.
Browse analyst ratings and price targets on all stocks.